Illustration: A. Canamucio I knew, back in March, that I was taking a gamble. The fourth edition of my human genetics textbook would be published in July, and judging from the rate of genomes being sequenced, it looked like Homo sapiens might join the list come summer. Unless the new edition assumed that the project was completed, my book would be obsolete before it was printed. So I E-mailed the great and powerful J. Craig Venter, president of Celera Genomics Group in Rockville, Md., to ask ab
| Illustration: A. Canamucio |
 |
Despite his image as Darth Vader--softened perhaps since the joint announcement on June 26 (see page 1)--Venter has always been exceptionally courteous to reporters. In my case, I had to do some rephrasing reminiscent of Bob Woodward and Carl Bernstein in All the President's Men to get him to admit that if a student were to read in late July that ...
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
In this webinar, Brian Hie will discuss Evo2, a state-of-the-art genomic foundation model capable of generalist prediction and design tasks across DNA, RNA, and proteins.
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
In the dynamic biotechnology and biopharmaceutical science fields, qPCR and dPCR multiplexing has emerged as a crucial technique for accelerated and consistent research workflows.
Manufacturing cell-based therapeutics requires a robust workflow from start to finish.
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
New fluidics and clog detection systems further simplify operation and reduce instrument downtime
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies
Study identifies new metrics to enhance scRNA-seq based virtual cell modelling
